Načítá se...

Racial-Ethnic Differences in Incident Olanzapine Use After an FDA Advisory for Patients With Schizophrenia

OBJECTIVE: Prior investigations suggest that olanzapine use declined rapidly after a U.S. Food and Drug Administration (FDA) communication and consensus statement warning of the drug’s increased metabolic risks, but whether declines differed by racial-ethnic groups is unknown. METHODS: Changes in ol...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Dusetzina, Stacie B., Cook, Benjamin L., Busch, Alisa B., Alexander, Caleb, Huskamp, Haiden A.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2013
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3572912/
https://ncbi.nlm.nih.gov/pubmed/23280461
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1176/appi.ps.201200002
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!